Chiesi forms new rare diseases business unit
Italian pharmaceutical company Chiesi Farmaceutici (Chiesi Group) has established a global division for the research...
Read More...
Focus:
Italy
-
![]()
Late-stage PsA pipeline agents must prove their worth
Despite the plethora of therapies currently available to patients with psoriatic arthritis (PsA), there is still room for improvement within…
Read More…
-
![gene therapy Genenta funding]()
Gene therapy biotech Genenta raises €13.2m in funding round
Milan-based clinical stage biotech Genenta Science has announced it has raised €13.2m at the closing...
Read More...
-
![Sofinnova sells Breath Therapeutics to Zambon]()
Sofinnova sells Breath Therapeutics to Zambon in $550m deal
Venture capital firm Sofinnova Partners has dispossessed its portfolio company Breath Therapeutics to Italian pharmaceutical...
Read More...
-
![Recordati acquires rights to Signifor and osilodrostat from Novartis]()
Recordati acquires rights to Signifor and osilodrostat from Novartis
Recordati has agreed to acquire the global rights to two of Novartis’ medicines, Signifor and...
Read More...
-
![Italy pharma industry]()
Inside Italy’s pharmaceutical industry
Last year, three of the five top US exports to Italy were health related, and...
Read More...
-
Win Transport Italy
Win Transport Italy is an international distribution company for time-critical and temperature-sensitive medical products.
Read More...
-
Deals this week: Olon SpA, MannKind, Shire
Olon SpA has agreed to purchase an active pharmaceutical ingredient (API) manufacturing plant located in...
Read More...
-
![]()
Italy’s Senate ends parental obligation to vaccinate school children
The upper house of Italy’s parliament has passed an amendment supported by the government to...
Read More...
-
M&As this week: Catalent, CVC, Bain Capital Private Equity
Catalent has agreed to acquire Juniper Pharmaceuticals, along with its Juniper Pharma Services division based...
Read More...